Your browser doesn't support javascript.
loading
Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial.
Bourgeois, Florence; Doshi, Peter; Hong, Kyungwan; Jefferson, Tom; Jones, Mark; Lee, Haeyoung; Rowhani-Farid, Anisa; Shamseer, Larissa; Spence, O'Mareen.
Afiliación
  • Bourgeois F; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Doshi P; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA pdoshi@rx.umaryland.edu.
  • Hong K; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Jefferson T; Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom.
  • Jones M; Nordic Cochrane Centre, Copenhagen, Denmark.
  • Lee H; Institute for Evidence-based Healthcare, Bond University, Gold Coast, Queensland, Australia.
  • Rowhani-Farid A; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Shamseer L; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Spence O; University of Ottawa, Ottawa, Ontario, Canada.
mSphere ; 5(6)2020 11 04.
Article en En | MEDLINE | ID: mdl-33148819

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Placebos / Grupos Control / Ensayos Clínicos como Asunto / Infecciones por Papillomavirus / Vacuna Tetravalente Recombinante contra el Virus del Papiloma Humano Tipos 6, 11 , 16, 18 / Exactitud de los Datos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: MSphere Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Placebos / Grupos Control / Ensayos Clínicos como Asunto / Infecciones por Papillomavirus / Vacuna Tetravalente Recombinante contra el Virus del Papiloma Humano Tipos 6, 11 , 16, 18 / Exactitud de los Datos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: MSphere Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos